Metabolism.com
  • Home
  • About us
  • The Thyroid Project
  • Health & Nutrition
  • Contact us
Select Page

New Diabetes Medications Cost 100 Times More than Established Treatments

by Gary Pepper M.D. | Oct 6, 2014 | diabetes, general health & nutrition, health insurance, Medical Economics

by Gary Pepper, M.D. “New is not always better.” This caution seems reasonable when considering the value of the recently approved medications for treatment of Type 2 (adult type) diabetes.  These drugs include three new classes of medication referred to...

Are New Diabetes Medications Worth the Money?

by Dr. G. Pepper | May 16, 2011 | diabetes, diet, general health & nutrition, health, metabolism, weight gain

(I don’t think so, and here’s why.) The FDA just announced its approval of linagliptin (Tradjenta), a new diabetes medication developed by Eli Lilly and Company and Boehringer Inglheim. Linagliptin is the third drug to be approved in the class of medications...

Categories

Polls

Has the Federal Government done enough to control the Covid crisis?

View Results

Loading ... Loading ...
  • Polls Archive

After graduating from fellowship in Endocrinology
and Metabolism at Mt. Sinai School of Medicine in
New York, in 1981.

COMPANY

  • Home
  • About Us
  • The Thyroid Project
  • Health & Nutrition
  • Contact Us

RESOURCES

  • Blog
  • Terms & Condidtions
  • Privcay Policy
  • Disclaimer

CONTACT US

  • info@metabolism.com
  • P.O. Box 2161, Jupiter,
    Florida 33468

Copyright © 2021 Metabolism.com

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.